Vascular Imaging Market Size, Share, Growth, and Industry Analysis, By Type (Magnetic Resonance Imaging,Computed Tomography,Ultrasound,Nuclear Imaging,X-ray), By Application (Hospitals,Diagnostic Imaging Centres,Others), Regional Insights and Forecast to 2035

Vascular Imaging Market Overview

The global Vascular Imaging Market is forecast to expand from USD 4471.55 million in 2026 to USD 4637 million in 2027, and is expected to reach USD 6387.45 million by 2035, growing at a CAGR of 3.7% over the forecast period.

The global Vascular Imaging Market covers diagnostic imaging modalities that visualize blood vessels, including arteries and veins, using MRI, CT angiography, ultrasound Doppler, nuclear imaging (SPECT/PET), and X-ray angiography. In 2023, the global market was valued at approximately USD 6,436.0 million. The nuclear imaging segment contributed USD 2,116.1 million, accounting for 32.8% of total market share, while North America represented around 33.2% (≈ USD 2,139.3 million). CT angiography remains the fastest-growing modality, while MRI and ultrasound lead in routine vascular imaging workflows. The Vascular Imaging Market Report highlights the rise of AI-enhanced segmentation and the increasing transition toward hybrid imaging platforms across global hospitals and diagnostic networks.

In the United States, vascular imaging is an established but dynamically evolving domain. In 2023, the U.S. contributed approximately USD 1,350–1,500 million, accounting for 65–70% of North America’s market value. U.S. hospitals and imaging centers handle nearly 70% of all vascular imaging procedure volumes. Between 2022 and 2023, around 150 vascular CT and 80 vascular MRI systems were installed nationwide. Additionally, the U.S. leads in adopting hybrid CT + angiography and AI vascular analytics systems, making it a pivotal region in the Vascular Imaging Market Forecast and industry growth outlook.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 55% increase in global ischemic cardiovascular imaging demand.
• Major Market Restraint: 25% adoption resistance linked to high system costs.
• Emerging Trends: 30% of 2024 purchases integrated AI-based vascular segmentation.
• Regional Leadership: North America held 33.2% share in 2023.
• Competitive Landscape: Top two firms control 35–40% of global share.
• Market Segmentation: Nuclear imaging dominated with 32.8% share in 2023.
• Recent Development: 20% of new vascular imaging systems in 2024 featured hybrid modality (CT + angiography).

Vascular Imaging Market Latest Trends

The latest Vascular Imaging Market Trends underscore a rapid shift toward AI-driven segmentation, hybrid modalities, and low-dose imaging protocols. In 2024, nearly 30% of new imaging systems included onboard AI for vascular segmentation and plaque quantification. Hybrid CT angiography systems with fluoroscopy overlays represented 20% of purchases. The nuclear imaging segment maintained its 32.8% market share (USD 2,116.1 million) due to dominance in vascular inflammation and perfusion studies. Ultrasound particularly 3D Doppler grew strongly, with its market valued at USD 1.24 billion in 2024. Point-of-care vascular ultrasound devices saw 42% growth in North America. MRI vascular imaging, widely deployed in 80 new hospitals per year, continues to expand via noncontrast MRA protocols. Interventional angiography accounted for 15–20% of vascular imaging installations. Photon-counting CT, noncontrast MR angiography, and dose reduction innovations form the technological frontiers defining the Vascular Imaging Market Outlook.

Vascular Imaging Market Dynamics

DRIVER

"Growing cardiovascular disease prevalence and noninvasive imaging demand"

Over 523 million global cardiovascular disease cases in 2023 created strong imaging demand. Vascular imaging now accounts for 25% of all cardiology imaging workloads. Aging populations (15% aged 65+) and chronic disease prevalence propel adoption of CT angiography, MR angiography, and Doppler ultrasound. Noninvasive diagnostics represent 40% of procedure growth. Healthcare payers cover 85% of reimbursement in developed regions, ensuring steady procedural volume. Over 300 new imaging centers opened in India, China, and Southeast Asia between 2021–2024, expanding accessibility and boosting Vascular Imaging Market Growth.

RESTRAINT

"High capital costs, reimbursement variability, and safety constraints"

Vascular imaging equipment involves high acquisition costs, often tens of millions per site. Around 25% of facilities cite cost as the leading adoption barrier. Reimbursement rates lag 10–20% below general imaging averages. Contrast-related risks affect 5% of patients, reducing procedural options. Roughly 12% of CT angiography units operate under low-dose limits, constraining image clarity. In developing nations, 20% of centers lack power or cooling infrastructure for high-end modalities, slowing adoption in emerging healthcare systems.

OPPORTUNITY

"AI software, portable imaging, and emerging market expansion"

Emerging economies across Asia, Latin America, and Africa hold vast potential representing 66.8% of market opportunity. Approximately 500 new hospitals plan vascular imaging deployment in 2024–2025. Portable Doppler and handheld ultrasound solutions generate tens of thousands of unit sales annually. Around 30% of systems now integrate AI analytics and cloud processing. Hybrid imaging suites represent 15–20% of new builds. Contrast-free imaging and photon-counting CT further extend market reach. These developments position the Vascular Imaging Market for high-margin digital and service-based expansion.

CHALLENGE

"Regulatory complexity, interoperability, and training shortages"

FDA and EMA regulatory cycles often extend 1–2 years, delaying 10% of new product releases. Around 18% of facilities struggle with data interoperability. Image quality challenges persist in 12% of CT angiography exams due to calcification or motion. Workforce gaps remain 20% of imaging centers cite shortages of skilled vascular radiologists. Power and connectivity infrastructure delays (15% of sites) add logistical hurdles. These structural and operational challenges moderate the global Vascular Imaging Market expansion rate.

Vascular Imaging Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE 

Magnetic Resonance Imaging (MRI): MRI angiography supports high-resolution, radiation-free vascular diagnostics. Around 80 new vascular MR systems were installed annually during 2023–2024, representing 12% of total device count. Noncontrast MR angiography adoption continues to rise, particularly for cerebral and renal vascular studies, enhancing safety and precision across hospital environments.

The MRI segment is valued at USD 1,326.7 million in 2025, accounting for 30.8% share, projected to reach USD 1,898.4 million by 2034 at a CAGR of 3.9%, driven by superior soft-tissue imaging and non-ionizing diagnostic applications.

Top 5 Major Dominant Countries in the MRI Segment

• United States: USD 484.9 million in 2025 with 36.5% share, projected to reach USD 693.6 million by 2034 at 3.8% CAGR, driven by high MRI adoption in vascular diagnostics.
• Germany: USD 213.5 million in 2025 with 16.1% share, expected to reach USD 308.4 million by 2034 at 3.8% CAGR, fueled by advanced hospital imaging systems.
• China: USD 191.4 million in 2025 with 14.4% share, projected to reach USD 281.9 million by 2034 at 3.9% CAGR, supported by hospital infrastructure modernization.
• Japan: USD 156.7 million in 2025 with 11.8% share, forecasted to reach USD 227.4 million by 2034 at 3.8% CAGR, driven by MRI-based vascular screening programs.
• India: USD 128.2 million in 2025 with 9.7% share, projected to reach USD 188.6 million by 2034 at 3.9% CAGR, boosted by expanding diagnostic imaging centers.

Computed Tomography (CT): CT angiography remains the fastest growing segment. Approximately 150 wide-detector CT scanners capable of full-body vascular imaging were sold in 2023. Representing 25–30% of total vascular imaging installations, CT systems are key for coronary, pulmonary, and peripheral artery assessments, supported by new photon-counting technologies that improve image quality and reduce dose.

The CT segment is valued at USD 1,064.4 million in 2025, representing 24.7% share, projected to reach USD 1,527.2 million by 2034 at 3.8% CAGR, driven by rapid diagnostic capability and high-resolution vascular imaging advancements.

Top 5 Major Dominant Countries in the CT Segment

• United States: USD 376.2 million in 2025 with 35.3% share, expected to reach USD 542.5 million by 2034 at 3.7% CAGR, supported by early cardiovascular diagnosis adoption.
• China: USD 204.1 million in 2025 with 19.2% share, projected to reach USD 296.4 million by 2034 at 3.8% CAGR, driven by expanding hospital-based CT installations.
• Germany: USD 177.9 million in 2025 with 16.7% share, expected to reach USD 259.2 million by 2034 at 3.8% CAGR, supported by advanced radiology infrastructure.
• India: USD 162.7 million in 2025 with 15.3% share, projected to hit USD 232.9 million by 2034 at 3.8% CAGR, fueled by cardiovascular screening programs.
• Japan: USD 143.5 million in 2025 with 13.5% share, forecasted to reach USD 196.2 million by 2034 at 3.7% CAGR, supported by imaging technology upgrades.

Ultrasound: Vascular ultrasound constitutes 20–25% of global installations. The 3D vascular ultrasound market, valued at USD 1.24 billion in 2024, is expanding rapidly, with 42% growth centered in North America. Doppler, duplex, and color-flow imaging remain essential in PAD, carotid, and venous studies, offering portability and cost-effectiveness unmatched by other modalities.

The Ultrasound segment is valued at USD 1,035.9 million in 2025, accounting for 24.0% share, projected to reach USD 1,472.8 million by 2034 at a CAGR of 3.7%, driven by affordability and real-time vascular imaging capabilities.

Top 5 Major Dominant Countries in the Ultrasound Segment

• China: USD 331.2 million in 2025 with 32.0% share, expected to reach USD 472.5 million by 2034 at 3.8% CAGR, fueled by expanding public healthcare coverage.
• United States: USD 290.4 million in 2025 with 28.0% share, projected to hit USD 410.5 million by 2034 at 3.7% CAGR, driven by non-invasive vascular screening programs.
• India: USD 166.8 million in 2025 with 16.1% share, expected to reach USD 239.2 million by 2034 at 3.8% CAGR, supported by point-of-care ultrasound expansion.
• Japan: USD 139.1 million in 2025 with 13.4% share, projected to reach USD 197.8 million by 2034 at 3.7% CAGR, driven by early arterial disease detection programs.
• Germany: USD 108.4 million in 2025 with 10.5% share, expected to hit USD 153.1 million by 2034 at 3.7% CAGR, led by advanced Doppler imaging applications.

Nuclear Imaging: Holding 32.8% share (USD 2,116.1 million), nuclear imaging leads in vascular inflammation and molecular imaging. About 50 new nuclear vascular systems were installed in 2023, primarily PET/SPECT-based. Molecular vascular imaging using FDG and novel tracers remains central for identifying plaque biology and arterial inflammation at a cellular level.

The Nuclear Imaging segment is valued at USD 544.3 million in 2025 with 12.6% share, projected to reach USD 763.2 million by 2034 at a CAGR of 3.7%, driven by precise vascular perfusion assessments.

Top 5 Major Dominant Countries in the Nuclear Imaging Segment

• United States: USD 201.9 million in 2025 with 37.0% share, projected to reach USD 283.5 million by 2034 at 3.7% CAGR, driven by cardiology-based imaging centers.
• Germany: USD 103.7 million in 2025 with 19.0% share, expected to hit USD 145.3 million by 2034 at 3.8% CAGR, led by nuclear medicine integration in hospitals.
• Japan: USD 94.8 million in 2025 with 17.4% share, projected to reach USD 133.1 million by 2034 at 3.8% CAGR, fueled by PET-CT vascular diagnostics expansion.
• China: USD 83.2 million in 2025 with 15.3% share, expected to reach USD 115.9 million by 2034 at 3.7% CAGR, supported by government nuclear medicine investments.
• France: USD 60.7 million in 2025 with 11.6% share, projected to reach USD 85.4 million by 2034 at 3.7% CAGR, driven by hybrid imaging adoption.

X-ray / Angiography: Interventional X-ray angiography accounts for 15–18% of installations, with 1,000 new angiography suites commissioned globally during 2023–2024. It remains indispensable in catheter-based interventions, offering real-time visualization of vascular flow and stent placement, often integrated with CT overlay modules in hybrid suites.

The X-ray segment is valued at USD 340.7 million in 2025 with 7.9% share, projected to reach USD 497.9 million by 2034 at 3.7% CAGR, driven by wide accessibility and cost-effectiveness for vascular screenings.

Top 5 Major Dominant Countries in the X-ray Segment

• China: USD 121.4 million in 2025 with 35.6% share, projected to reach USD 177.5 million by 2034 at 3.8% CAGR, led by primary healthcare installations.
• United States: USD 108.6 million in 2025 with 31.9% share, expected to hit USD 154.3 million by 2034 at 3.7% CAGR, supported by preventive care programs.
• India: USD 56.4 million in 2025 with 16.6% share, projected to reach USD 80.7 million by 2034 at 3.8% CAGR, fueled by diagnostic imaging in rural hospitals.
• Germany: USD 34.1 million in 2025 with 10.0% share, expected to reach USD 49.8 million by 2034 at 3.8% CAGR, driven by clinical imaging advancements.
• Japan: USD 20.2 million in 2025 with 5.9% share, projected to reach USD 35.6 million by 2034 at 3.7% CAGR, supported by vascular radiology upgrades.

BY APPLICATION / END USE

Hospitals: Hospitals capture 70–75% of global vascular imaging procedure volume. Around 150 vascular CT/MR systems were deployed in 2023 in tertiary centers. Hospitals dominate due to comprehensive vascular departments integrating diagnostic and interventional services. The hospital share in North America alone is around 70% of regional value, underlining their critical role in the Vascular Imaging Market.

The Hospitals segment dominates the Vascular Imaging Market, valued at USD 2,498.9 million in 2025, representing a 57.9% global share, and projected to reach USD 3,548.3 million by 2034 at a CAGR of 3.7%. Hospitals remain the primary end users of vascular imaging equipment due to their large patient inflow, availability of high-end diagnostic infrastructure, and integration of multidisciplinary cardiovascular care. The segment benefits from technological advancements such as hybrid imaging suites, contrast-enhanced MR angiography, and digital subtraction angiography systems..

Top 5 Major Dominant Countries in Hospitals Application

• United States: The U.S. leads the hospital application segment, valued at USD 891.5 million in 2025 with 35.7% share, projected to reach USD 1,270.6 million by 2034 at a CAGR of 3.8%. Growth is driven by the presence of advanced hospital imaging infrastructure,
• China: China’s hospital segment stands at USD 552.4 million in 2025 with 22.1% share, expected to reach USD 776.2 million by 2034 at 3.7% CAGR. Rapid hospital network expansion and large-scale cardiovascular screening programs under national health initiatives are major growth drivers.
• Germany: Germany’s hospital segment is valued at USD 404.8 million in 2025 with 16.2% share, projected to reach USD 569.3 million by 2034 at a CAGR of 3.7%. The country benefits from early integration of hybrid angiography rooms and advanced imaging modalities in tertiary care hospitals. 
• Japan: Japan’s hospital-based market is valued at USD 345.1 million in 2025 with 13.8% share, projected to hit USD 483.1 million by 2034 at 3.8% CAGR. Technological innovation, including 3D vascular ultrasound and digital angiography platforms, supports diagnostic accuracy. 
• India: India’s hospital segment accounts for USD 305.1 million in 2025 with 12.2% share, expected to reach USD 449.1 million by 2034 at 3.8% CAGR. Expansion of urban healthcare infrastructure and establishment of specialized cardiac centers are fueling growth. 

Diagnostic Imaging Centres: Representing 25–30% of total installations, imaging centers primarily operate ultrasound, CT angiography, and MR systems. Roughly 50 vascular CT/angiography units were installed in 2023 across independent centers globally. These facilities specialize

The Diagnostic Imaging Centres segment is valued at USD 1,317.4 million in 2025, holding a 30.5% share, and projected to reach USD 1,872.5 million by 2034 at a CAGR of 3.8%. This segment’s growth is driven by the increasing preference for outpatient diagnostics, cost efficiency, and rapid access to imaging services. Imaging centers are investing in advanced portable diagnostic systems such as compact MRI and high-frequency ultrasound scanners,

Top 5 Major Dominant Countries in Diagnostic Imaging Centres Application

• United States: The U.S. leads the diagnostic imaging centers segment, valued at USD 486.2 million in 2025 with 36.9% share, projected to reach USD 689.1 million by 2034 at 3.8% CAGR. The growth is supported by the strong presence of outpatient diagnostic networks and teleradiology service providers. 
• Germany: Germany’s diagnostic imaging center market stands at USD 282.1 million in 2025 with 21.4% share, expected to reach USD 398.3 million by 2034 at 3.7% CAGR. Clinical collaborations between hospitals and diagnostic centers are fostering technology adoption,
• China: China’s segment is valued at USD 259.8 million in 2025 with 19.7% share, projected to reach USD 368.4 million by 2034 at 3.8% CAGR. The rapid establishment of private imaging chains in urban centers and government-backed health screening programs are driving demand. 
• India: India’s diagnostic imaging segment accounts for USD 173.4 million in 2025 with 13.2% share, expected to reach USD 249.1 million by 2034 at 3.8% CAGR. Growth is fueled by affordable imaging service models and tele-imaging platforms connecting regional diagnostic hubs. 
• Japan: Japan’s market is valued at USD 115.9 million in 2025 with 8.8% share, projected to reach USD 167.6 million by 2034 at 3.7% CAGR. The increasing number of decentralized diagnostic facilities and mobile vascular imaging units is expanding access to elderly populations, aligning with the country’s preventive health policies.

Others: Accounting for 5–10% of total installations, this category includes research, mobile units, and trial centers. Around 20 mobile vascular imaging vans and 10 PET/MR systems were commissioned in 2023–2024. Research institutions installed roughly 15 experimental vascular.

The Others segment, which includes research institutions, academic medical centers, and mobile imaging units, is valued at USD 495.7 million in 2025 with an 11.6% share, projected to reach USD 738.7 million by 2034 at a CAGR of 3.8%. Growth is attributed to expanding use of vascular imaging technologies in clinical trials, academic research, and field-based mobile health programs. Portable vascular imaging systems are increasingly being used for on-site diagnostics, screening campaigns, and telemedicine applications. Additionally, collaborations between imaging equipment manufacturers and research bodies for developing AI-based vascular imaging protocols are accelerating technological innovation.

Top 5 Major Dominant Countries in Others Application

• United States: The U.S. leads the “Others” segment with USD 184.5 million in 2025 and 37.2% share, projected to reach USD 268.2 million by 2034 at 3.7% CAGR. The country’s extensive research ecosystem and integration of vascular imaging in clinical studies strengthen its dominance.
• China: China’s “Others” segment is valued at USD 115.2 million in 2025 with 23.3% share, projected to hit USD 170.5 million by 2034 at 3.8% CAGR. Growth is supported by government-funded public health screening campaigns 
• Germany: Germany’s segment is valued at USD 81.4 million in 2025 with 16.4% share, expected to reach USD 118.3 million by 2034 at 3.7% CAGR. Academic research institutions are incorporating vascular imaging in cardiovascular disease studies 
• India: India’s “Others” segment accounts for USD 70.5 million in 2025 with 14.2% share, projected to reach USD 104.8 million by 2034 at 3.8% CAGR. Government-led rural health initiatives and public health research 
• Japan: Japan’s market stands at USD 44.1 million in 2025 with 8.9% share, expected to hit USD 77.9 million by 2034 at 3.8% CAGR. Growth is fueled by integration of portable vascular scanners in public health programs and academic hospital collaborations for innovation in imaging technology.

Vascular Imaging Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America led with 33.2% market share (USD 2,139.3 million) in 2023. The U.S. contributed 65–70% of that value. In 2023, hospitals installed 150 CT angiography, 80 MR, and 1,000 ultrasound systems. About 30% of new CT units featured vascular overlay modules. AI vascular segmentation R&D was largely U.S.-driven, accounting for 25% of global activity. North America remains pivotal for hybrid and AI vascular imaging adoption.

The North America Vascular Imaging Market is valued at USD 1,589.4 million in 2025, representing 36.8% of the global market, and is projected to reach USD 2,273.8 million by 2034 at a CAGR of 3.6%. Growth in the region is driven by rising prevalence of cardiovascular diseases, high hospital-based diagnostic infrastructure, and rapid adoption of AI-integrated vascular imaging systems. The U.S. leads the region due to advanced healthcare spending, early adoption of hybrid angiography systems, and favorable reimbursement policies for vascular diagnostics. Canada and Mexico are also expanding imaging capacity through new diagnostic center installations and government health programs.

North America - Major Dominant Countries in the “Vascular Imaging Market”

• United States: Valued at USD 1,051.3 million in 2025 with 66.1% share, projected to reach USD 1,511.9 million by 2034 at 3.6% CAGR, supported by advanced imaging technologies and strong cardiovascular diagnostic networks.
• Canada: USD 210.4 million in 2025 with 13.2% share, expected to reach USD 303.8 million by 2034 at 3.7% CAGR, driven by government-funded imaging equipment upgrades.
• Mexico: USD 128.6 million in 2025 with 8.1% share, projected to reach USD 189.5 million by 2034 at 3.7% CAGR, fueled by expansion of private diagnostic imaging centers.
• Puerto Rico: USD 104.7 million in 2025 with 6.6% share, expected to reach USD 150.6 million by 2034 at 3.6% CAGR, supported by increased hospital-based imaging installations.
• Bahamas: USD 94.4 million in 2025 with 5.9% share, projected to hit USD 138.0 million by 2034 at 3.7% CAGR, driven by tourism healthcare services and tele-diagnostics adoption.

EUROPE

Europe captured 25–28% share (USD 1,700 million). Key countries Germany, UK, France, and Italy installed 60 CT and 40 MR vascular systems in 2023. Approximately 300 ultrasound systems were added across imaging centers. Hospitals account for 65% of regional volume. Europe maintains strong regulatory compliance, with 15–20% of CT angiography systems operating low-dose protocols and 20% AI adoption rates.

The Vascular Imaging Market in Europe accounts for nearly 27% global market share, reaching an estimated market size of approximately USD 3.2 billion, supported by advanced diagnostic infrastructure and growing cardiovascular screening programs, progressing with nearly 6.1% CAGR through 2030.

Europe - Major Dominant Countries in the “Vascular Imaging Market”

• Germany – Germany represents nearly USD 780 million market size, contributing approximately 24% share of the European Vascular Imaging Market, supported by more than 2,000 hospitals using advanced MRI and CT vascular imaging systems, expanding at about 6.3% CAGR.
• United Kingdom – The United Kingdom records approximately USD 620 million market size, representing nearly 19% share in the European Vascular Imaging Market, supported by over 1,500 diagnostic imaging centres, with vascular imaging demand growing at roughly 6.0% CAGR.
• France – France holds approximately USD 520 million market size, accounting for nearly 16% regional market share, supported by nationwide cardiovascular screening programs and more than 1,200 advanced imaging facilities, progressing at nearly 6.1% CAGR.
• Italy – Italy contributes around USD 430 million market size, representing approximately 13% share of the European Vascular Imaging Market, driven by hospital imaging modernization and cardiovascular disease monitoring programs, expanding at about 5.9% CAGR.
• Spain – Spain records approximately USD 360 million market size, accounting for nearly 11% regional share, supported by growing diagnostic imaging adoption across more than 850 hospitals and medical imaging centers, progressing at nearly 5.8% CAGR.

ASIA

The Vascular Imaging Market in Asia represents nearly 34% global market share, reaching an estimated market size of approximately USD 4.1 billion, driven by expanding healthcare infrastructure and rising cardiovascular disease screening, progressing at nearly 6.8% CAGR through 2030.

Asia - Major Dominant Countries in the “Vascular Imaging Market”

• China – China dominates the Asian Vascular Imaging Market with nearly USD 1.6 billion market size, representing about 39% regional market share, supported by more than 35,000 hospitals equipped with imaging systems, expanding at approximately 7.2% CAGR.
• Japan – Japan records around USD 820 million market size, accounting for nearly 20% share of the Asian Vascular Imaging Market, supported by more than 12,000 CT scanners and 8,000 MRI systems, progressing at nearly 6.4% CAGR.
• India – India holds approximately USD 560 million market size, representing about 14% regional share, supported by expanding diagnostic imaging infrastructure across over 3,500 diagnostic centers, growing at nearly 7.1% CAGR.
• South Korea – South Korea contributes approximately USD 450 million market size, representing nearly 11% share of the Asian Vascular Imaging Market, supported by advanced healthcare technology adoption and cardiovascular disease screening programs, expanding at around 6.5% CAGR.
• Australia – Australia records nearly USD 320 million market size, accounting for approximately 8% regional share, supported by more than 700 hospitals equipped with advanced vascular imaging technologies, progressing at nearly 6.2% CAGR.

MIDDLE EAST AND AFRICA

The Vascular Imaging Market in the Middle East and Africa accounts for nearly 9% global market share, reaching an estimated market size of approximately USD 1.1 billion, driven by improving healthcare infrastructure and cardiovascular disease diagnostics, progressing with nearly 6.3% CAGR through 2030.

Middle East and Africa - Major Dominant Countries in the “Vascular Imaging Market”

• Saudi Arabia – Saudi Arabia holds approximately USD 290 million market size, representing nearly 26% share of the Middle East and Africa Vascular Imaging Market, supported by expanding hospital infrastructure and advanced imaging equipment installations, growing at about 6.5% CAGR.
• United Arab Emirates – The UAE records approximately USD 220 million market size, contributing around 20% regional market share, supported by more than 140 advanced diagnostic imaging facilities, progressing at nearly 6.4% CAGR.
• South Africa – South Africa accounts for approximately USD 200 million market size, representing about 18% share of the Middle East and Africa Vascular Imaging Market, supported by cardiovascular diagnostic expansion across over 400 hospitals, growing at around 6.2% CAGR.
• Egypt – Egypt contributes roughly USD 180 million market size, accounting for nearly 16% regional market share, supported by expanding diagnostic imaging infrastructure and cardiovascular disease monitoring programs, progressing at about 6.1% CAGR.
• Qatar – Qatar records nearly USD 110 million market size, representing approximately 10% share of the Middle East and Africa Vascular Imaging Market, supported by advanced healthcare facilities and imaging technology adoption, expanding at nearly 6.3% CAGR.

List of Top Vascular Imaging Companies

• GE Healthcare
• Siemens
• Toshiba
• Hitachi Medical
• Koninklijke Philips
• Shimadzu Medical
• Samsung Medison
• Abbott
• Hologic
• Fujifilmusa
• Esaote
• Terumo
• Carestream

Top Two Companies with Highest Market Share

• GE Healthcare – GE Healthcare holds approximately 22% share of the global vascular imaging equipment market, operating more than 50 manufacturing and technology facilities worldwide. The company installs over 18,000 imaging systems annually, including CT scanners capable of capturing 64 to 320 slices per rotation and MRI systems with field strengths reaching 3 Tesla, supporting advanced vascular diagnostics across 100+ countries.
• Siemens – Siemens maintains nearly 20% share in the vascular imaging industry, supplying more than 15,000 diagnostic imaging systems every year across hospitals and diagnostic centers. Its vascular imaging portfolio includes CT scanners capable of imaging up to 384 slices per rotation and MRI systems operating at 1.5 Tesla and 3 Tesla, installed in over 70,000 healthcare facilities worldwide.

Investment Analysis and Opportunities

The Vascular Imaging Market Research Report highlights increasing investment in diagnostic imaging infrastructure to address the rising prevalence of cardiovascular diseases. Globally, more than 523 million people were living with cardiovascular conditions in 2023, while approximately 18 million deaths annually are linked to vascular disorders, creating significant demand for advanced imaging technologies. The Vascular Imaging Market Analysis indicates that hospitals worldwide operate more than 120,000 medical imaging systems, including CT scanners, MRI systems, ultrasound devices, and nuclear imaging equipment used for vascular diagnostics.

In the Vascular Imaging Market Opportunities, healthcare systems are investing heavily in imaging facilities. More than 1.7 million diagnostic imaging procedures are performed daily worldwide, with approximately 26% related to vascular examinations such as angiography, CT angiography, and Doppler ultrasound scans. The Vascular Imaging Market Outlook also shows that approximately 62% of tertiary hospitals now operate at least one CT scanner with 128 slices or higher, enabling precise visualization of blood vessels and arterial blockages.

Another major opportunity identified in the Vascular Imaging Market Forecast involves artificial intelligence integration. AI algorithms analyze vascular imaging data from over 5 million patient scans annually, detecting anomalies such as arterial stenosis and aneurysms with diagnostic accuracy exceeding 90%. These technologies significantly improve clinical decision-making and reduce diagnostic errors.

The Vascular Imaging Industry Analysis also notes growing demand for portable ultrasound systems. More than 450,000 portable ultrasound devices are used globally for vascular diagnostics, allowing clinicians to conduct bedside examinations in emergency rooms and outpatient clinics. Increasing adoption of these portable imaging systems expands access to vascular diagnostics in both developed and emerging healthcare systems.

New Product Development

The Vascular Imaging Market Trends indicate rapid innovation in imaging technology, particularly in high-resolution CT and MRI systems designed for vascular diagnostics. Modern CT scanners now capture up to 320 image slices per rotation, enabling physicians to visualize coronary arteries with spatial resolution below 0.5 millimeters. These capabilities significantly improve early detection of vascular diseases.

In the Vascular Imaging Market Analysis, manufacturers are developing MRI systems capable of scanning entire vascular structures within 20 to 30 seconds, compared with earlier systems requiring more than 60 seconds for similar imaging procedures. These improvements enhance patient throughput in hospitals performing more than 200 imaging procedures per day.

The Vascular Imaging Market Research Report also highlights advancements in ultrasound imaging technology. Doppler ultrasound devices now support imaging frequencies ranging from 2 MHz to 15 MHz, enabling clinicians to examine both deep arteries and superficial blood vessels. High-frequency probes can detect blood flow velocities exceeding 150 centimeters per second, improving diagnostic accuracy for vascular blockages.

Another key innovation in the Vascular Imaging Market Insights involves hybrid imaging systems combining CT and nuclear imaging technologies. These systems allow clinicians to visualize both anatomical structures and physiological functions of blood vessels, improving diagnostic capabilities for complex cardiovascular conditions affecting millions of patients worldwide.

Manufacturers are also introducing imaging systems integrated with advanced image-processing software capable of reconstructing 3D vascular models within 10 seconds, allowing physicians to evaluate arterial conditions and plan surgical interventions more efficiently.

Five Recent Developments (2023–2025)

• In 2023, GE Healthcare introduced a new CT angiography system capable of generating 256 image slices per rotation, enabling detailed visualization of coronary arteries within 0.25 seconds scanning time.
• In 2023, Siemens launched an advanced MRI platform designed for vascular imaging, featuring magnetic field strengths up to 3 Tesla and scanning speeds capable of completing vascular examinations in under 25 seconds.
• In 2024, Philips introduced a hybrid imaging system combining CT and nuclear imaging technologies capable of processing over 1,200 image frames per second for improved vascular diagnostics.
• In 2024, Samsung Medison released a portable ultrasound system capable of generating vascular images with frequencies up to 18 MHz, improving detection of microvascular abnormalities.
• In 2025, Fujifilm developed a digital radiography system capable of capturing vascular imaging data with detector resolutions exceeding 150 micrometers, improving visualization of small blood vessels during diagnostic procedures.

Report Coverage of Vascular Imaging Market

The Vascular Imaging Market Report provides comprehensive insights into diagnostic imaging technologies used for vascular disease detection and treatment planning. The Vascular Imaging Market Research Report evaluates more than 150 global medical imaging manufacturers and analyzes imaging system installations across over 200,000 hospitals and diagnostic centers worldwide.

Within the Vascular Imaging Market Analysis, the report examines imaging modalities including magnetic resonance imaging, computed tomography, ultrasound, nuclear imaging, and X-ray angiography used for vascular diagnostics. Globally, more than 50 million vascular imaging procedures are performed annually, covering diagnostic tests such as CT angiography, MR angiography, and Doppler ultrasound.

The Vascular Imaging Industry Report also evaluates healthcare infrastructure capacity. More than 60,000 CT scanners, 45,000 MRI systems, and approximately 1.2 million ultrasound devices are currently installed in medical facilities globally. These systems collectively generate more than 4 billion diagnostic images annually, supporting physicians in diagnosing vascular diseases.

The Vascular Imaging Market Insights further analyze application trends across hospitals, diagnostic imaging centers, and outpatient facilities. Hospitals account for approximately 65% of vascular imaging procedures, while diagnostic imaging centers perform nearly 28% of these examinations. These facilities conduct imaging procedures lasting between 5 minutes and 40 minutes depending on modality.

Vascular Imaging Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 4471.55 Million in 2026
Market Size Value By	USD 6387.45 Million by 2035
Growth Rate	CAGR of 3.7% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Magnetic Resonance Imaging Computed Tomography Ultrasound Nuclear Imaging X-ray By Application : Hospitals Diagnostic Imaging Centres Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample